Spica Healthcare — Unit of Grover Hospital, Bathinda
HomeHealth Guides & BlogsGeneral Orthopaedics & Spine CareScedosporium Spondylodiscitis: Why Early ICU Sputum Cultures Shouldn't Be Dismissed as Colonization
General Orthopaedics & Spine Care

Scedosporium Spondylodiscitis: Why Early ICU Sputum Cultures Shouldn't Be Dismissed as Colonization

11 min read
Aug 28, 2026
Clinical MRI showing thoracolumbar fungal spondylodiscitis with disc space narrowing

Clinical Summary & Key Takeaways

A peer-reviewed clinical analysis by Dr. Deepak Garg on the newly published JBJS report of Scedosporium apiospermum spondylodiscitis after near-drowning. Explores why early ICU sputum cultures should not be dismissed as colonization, biopsy challenges, and Voriconazole pharmacodynamics.

New Evidence on Delayed Fungal Vertebral Osteomyelitis in Immunocompetent Patients

Spondylodiscitis comprises vertebral osteomyelitis, spondylitis, and discitis. It is most commonly caused by Gram-positive bacteria, primarily Staphylococcus aureus, whereas fungal spondylodiscitis is exceedingly rare, historically accounting for under 5% of spinal infections and predominantly confined to severely immunocompromised patients.

A newly published clinical investigation in the Journal of Bone and Joint Surgery (JBJS Case Connector, August 2026) from Amsterdam University Medical Center presents a critical analysis of delayed fungal spondylodiscitis caused by Scedosporium apiospermum in a previously healthy, immunocompetent 20-year-old male following accidental vehicular water submersion. The study highlights how pathogens identified in acute post-submersion respiratory cultures can easily be dismissed as benign colonization, leading to significant diagnostic delay.

What Did the Case Report Document?

The patient was involved in a single-vehicle car accident resulting in water submersion in an artificial canal with semistagnant water for approximately 5 minutes. Initial resuscitation achieved spontaneous circulation after pulseless electrical activity (PEA). Trauma CT showed bilateral pneumothorax and pulmonary aspiration without intracranial, abdominal, or spinal injury.

In the ICU, the patient developed ARDS, was placed on ECMO, and received intravenous prednisolone (70 mg/day for 5 days) for bronchospasm, alongside empiric IV ceftriaxone (2 g QD) and ciprofloxacin (400 mg TID). Sputum cultures grew Staphylococcus aureus, Stenotrophomonas maltophilia, Achromobacter species, Pantoea septica, Aspergillus fumigatus, and Scedosporium species. Because the patient improved clinically on room air with a normal leukocyte count (5.1 × 10⁹/L), antimicrobials were discontinued at Day 7 without initiating targeted antifungal therapy, as the sputum isolates were deemed non-pathogenic colonization.

The Critical Pitfall: Sputum Colonization vs. True Invasive Pathogen

Interpretation of early respiratory cultures after near-drowning is notoriously challenging. A multicenter cohort study from France (Reizine et al., Clin Microbiol Infect 2023) demonstrated that microbiologically proven pathogens in drowning-associated pneumonia are identified far less often than clinical pneumonia, highlighting significant discordance between early cultures and true causative organisms. In aspiration scenarios, early samples are frequently contaminated by oropharyngeal flora, while difficult-to-culture opportunistic molds like Scedosporium silently translocate across damaged alveolar-capillary membranes into the arterial circulation.

The Biopsy Journey: Overcoming False Negatives and Non-Causative Isolates

Two months post-trauma, when radiographs and MRI confirmed spondylodiscitis with elevated CRP (29 mg/L) and ESR (30 mm/h), establishing the microbiological diagnosis required a rigorous multi-step approach:

1. Initial Biopsy & Serology: The initial CT-guided biopsy of L1-2 grew no potential causal pathogens on routine cultures. Intergenic spacer profiling (IS-pro sequencing) identified Bacillus smithii, which was dismissed as non-causative due to low human pathogenicity. The serum (1-3)-β-D-glucan test was negative, histology showed only non-specific chronic inflammation without micro-organisms, and blood cultures remained negative.

2. Confirmatory Second Biopsy: A second CT-guided biopsy targeting levels L1-2 and Th10-11 successfully isolated Scedosporium apiospermum complex through routine mycological methods, demonstrating susceptibility to first-line Voriconazole.

Antifungal Pharmacodynamics: Why Voriconazole is First-Line over Amphotericin B

In accordance with combined European and American guidelines for rare mold infections (Hoenigl et al., Lancet Infect Dis 2021), oral Voriconazole 400 mg daily (200 mg BID) represents first-line therapy. Amphotericin B was explicitly dismissed due to poor activity against Scedosporium species, supported by an inherently high minimum inhibitory concentration (MIC) of 8 mg/L.

When the patient developed an allergic drug reaction (lip edema and skin ulceration) at Week 6, cross-reactivity with other azoles was considered likely. Due to limited alternative antifungals, clinicians adapted a structured 'watchful waiting' protocol with PET-CT at 7 months (confirming resolving FDG uptake and stable 24° kyphosis). At 1.5-year follow-up, complete anterior fusion at L1-2 and stable incomplete anterior fusion at Th10-11 were achieved with normalized inflammatory markers (CRP < 0.6 mg/L, ESR 2 mm/h) and full functional recovery without open surgery.

Review of Global Literature: 15 Cases in Immunocompetent Patients

To date, only approximately 15 cases of Scedosporium apiospermum spondylodiscitis have been reported in immunocompetent patients worldwide (including series by German et al., Levine et al., Garzoni et al., Mesfin et al., Blasco-Lucas et al., Cao et al., and Yan et al.). The documented diagnostic delay ranges from 28 to 120 days. Nearly all previous reports describe patients presenting with neurological deficits or requiring surgical corpectomy/instrumentation with prolonged voriconazole courses reaching up to 12 months.

My Take on the Findings — Dr. Deepak Garg

The central message of this study is that opportunistic pathogens identified after near-drowning should not be dismissed as colonization. When evaluating post-trauma spinal pain, cross-referencing initial ICU sputum records provides invaluable diagnostic clues. Furthermore, when non-diagnostic biopsies occur, repeating the image-guided biopsy is essential to avoid treating rare fungal pathogens with ineffective empiric antibacterials.

Take-Home Message

• Scedosporium apiospermum can cause delayed spondylodiscitis in young, immunocompetent patients following water submersion.

• Initial positive sputum cultures in the ICU may serve as early diagnostic sentinels rather than harmless colonization.

• (1-3)-β-D-glucan assays and initial needle biopsies may be false-negative; repeat CT-guided disc biopsy is warranted when endplate destruction progresses.

• Voriconazole is the preferred first-line therapy; Amphotericin B is ineffective due to high inherent MIC (8 mg/L).

• PET-CT and serial CRP/ESR surveillance allow successful conservative watchful waiting when drug hypersensitivity forces early treatment cessation.

Educational Disclaimer: This article is intended for medical education and scientific discussion. Individual clinical decisions must be guided by specialist evaluation and comprehensive microbiological workup.

Reference / Bibliography

1. Koning JDR, Baltes TPA, Geeraedts L Jr, van Daalen F, van Elzakker E, Stadhouder A. Delayed Complication of Near-Drowning Following a Car Crash: Spondylodiscitis by Scedosporium apiospermum. A Case Report. JBJS Case Connect. 2026;16(3):e26.00200. doi:10.2106/JBJS.CC.26.00200.

2. Hoenigl M, Salmanton-García J, Walsh TJ, et al. Global guideline for the diagnosis and management of rare mould infections. Lancet Infect Dis. 2021;21(8):e246-e257.

3. Reizine F, Delbove A, Tattevin P, et al. Clinical and microbiological features of drowning-associated pneumonia: a retrospective multicentre cohort study. Clin Microbiol Infect. 2023;29(1):108.e7-108.e13.

Frequently Asked Patient Questions

Limb Salvage with modular titanium megaprosthesis removes the tumor completely while preserving the limb, allowing patients to walk, work, and maintain full social independence without the physical disability of an artificial limb.

Dr. Deepak Garg - Director & Senior Joint Replacement, Spine and Orthopaedic Oncologist

Senior Consultant & Clinical Director — Orthopaedic Oncology & Robotic Joint Surgery

MBBS (TNMC Mumbai), DNB Orthopaedics (PGI & SP Miraj), Fellowship Arthroplasty and Arthroscopy (Fortis Hospital, New Delhi), Fellowship Orthopaedic Oncology (Rajiv Gandhi Cancer Institute, New Delhi)

Share this medical guide:
WhatsApp
Director-Led Clinical Breakthroughs

Signature Surgical Innovations & Techniques

Proprietary surgical methodologies and precision protocols pioneered by our senior directors to minimize trauma, protect natural anatomy, and accelerate recovery.

1 of 13
Comprehensive Bone Cancer Oncology & Limb Preservation
Click to Watch Video Demonstration
95%+ Limb Salvage & MAP Chemotherapy
Multidisciplinary Limb Salvage, MAP Chemotherapy & Modular Megaprosthetics

Comprehensive Bone Cancer Oncology & Limb Preservation

Dr. Deepak Garg (Orthopaedic Surgical Oncology - RGCI Delhi Trained) and Dr. Neha Gupta (Medical Oncology) co-lead the Bone Cancer & Sarcoma Center at Spica Healthcare. Integrating intensive multi-agent neoadjuvant chemotherapy protocols (MAP: High-Dose Methotrexate, Doxorubicin, Cisplatin for Osteosarcoma; VIDE: Vincristine, Ifosfamide, Doxorubicin, Etoposide for Ewing Sarcoma) with 3D computer-navigated limb salvage surgery and modular titanium megaprosthetic joint reconstruction, 5-year survival rates exceed 75% to 80% while saving over 95% of patients from limb amputation.

Key Advantages Over Conventional Surgery:
Coordinated Surgical & Medical Oncology: Seamless dual leadership under Dr. Deepak Garg & Dr. Neha Gupta
95%+ Limb Preservation Rate: Wide oncological bone resection avoiding traumatic limb amputations
High-Grade Sarcoma Chemotherapy: Standardized MAP and VIDE protocols delivering high tumor necrosis rates (>90%)
Custom Modular Megaprostheses: Immediate joint restoration with biological tendon ingrowth collars
Why Families & Physicians Trust Spica

World-Class Clinical Precision, Built on Compassion

Spica Healthcare — Bone and Cancer Institute, Bathinda — is South-Western Punjab's premier super-speciality centre led by AIIMS and Tata Memorial fellowship-trained directors.

AIIMS & Tata Memorial Alumni25+ Yrs Combined Senior Leadership

15,000+ Complex Surgeries & 100% Director-Led Evaluations

Every diagnostic MRI review, surgical staging, and operation is personally directed by chief clinical specialists — Dr. Deepak Garg (Orthopaedic Oncology & Robotics) and Dr. Neha Gupta (Medical Oncology) — guaranteeing zero junior proxies.

15,000+Surgeries Completed
95%+Limb Salvage Rate
<0.3%Infection Benchmark
Pre-Op 3D Virtual Planning 100% Direct Director OPD Day-1 Walking Protocol
Sub-Millimeter Accuracy

3D Navigated Robotics & Day-1 Walking

Sub-millimeter implant positioning and soft-tissue ligament balancing ensuring patients walk comfortably within 24 hours of total knee replacement.

ROSA Robotics & Stryker Nav
Malwa Punjab Exclusive

Limb-Salvage Over Amputation

South-West Punjab's only dedicated centre for modular titanium megaprosthesis, saving natural limbs and functions in 95%+ of bone cancer patients.

Modular Megaprosthesis
0-Out-Of-Pocket Options

100% Cashless PM-JAY & TPAs

Full cashless coverage for Ayushman Bharat (PM-JAY), Punjab Govt Health Schemes, ECHS, and 30+ private insurance networks with on-desk approvals.

Ayushman + 30+ TPAs Empanelled
24/7 Tertiary Ready

Class-100 Laminar Flow OTs & ICU

Positive-pressure HEPA filtered theatres minimizing infection rates below international benchmarks with 24/7 dedicated critical care backup.

Spica Healthcare Bathinda
Expert Surgical Directors

Meet the Doctors at Spica Healthcare

Fellowship-trained surgical directors from AIIMS & Tata Memorial providing compassionate, world-class tertiary care in super-speciality orthopaedics and medical oncology.

Dr. Neha Gupta - Clinical Director & Senior Medical Oncologist

Dr. Neha Gupta

Senior Consultant & Clinical Director — Medical Oncology

13+ Yrs Exp

MBBS (BFUHS Faridkot), MD Radiation Oncology (BFUHS Faridkot), DrNB Medical Oncology (Sarvodaya Hospital, Faridabad), Precision Oncology (Harvard, USA), Ex Consultant RGCI New Delhi

Medical Oncology & ChemotherapyImmunotherapy & Targeted OncologyPrecision Oncology & Cancer GenomicsPreventive Cancer ScreeningPalliative & Supportive OncologyHormonal TherapyComprehensive Cancer Treatments
Dr. Deepak Garg - Director & Senior Joint Replacement, Spine and Orthopaedic Oncologist

Dr. Deepak Garg

Senior Consultant & Clinical Director — Orthopaedic Oncology & Robotic Joint Surgery

16+ Yrs Exp

MBBS (TNMC Mumbai), DNB Orthopaedics (PGI & SP Miraj), Fellowship Arthroplasty and Arthroscopy (Fortis Hospital, New Delhi), Fellowship Orthopaedic Oncology (Rajiv Gandhi Cancer Institute, New Delhi)

Orthopaedic Oncology & Bone Tumors3D Robotic Joint ReplacementSports Injuries & ArthroscopyTrauma & Fracture ReconstructionGeneral Orthopaedics & Spine CareComprehensive Cancer Treatments
Community Health & Academic Outreach

Upcoming Health Camps & Academic Events

Free OPD screening camps, director-led masterclasses, and national oncology representations by Spica Healthcare.

Curious what families & patients experience

Hear what our patients are saying

Real stories from patients who recovered through limb preservation surgery, 3D robotic joint replacements, and precision cancer care at Spica Healthcare — Grover Hospital, Bathinda.

Health Knowledge & Clinical Guides

Doctor-Authored Health Guides

Evidence-based surgical recovery roadmaps, robotic joint protocols, and precision oncology insights written by our clinical directors.